Asenapine augmentation in bipolar disorders: a case series

Asenapine, a novel second‐generation antipsychotic is effective in acute treatment of bipolar I disorder patients in combination with mood stabilizers even in resistant cases. Although there is no evidence for asenapine's efficacy to be superior to currently available agents, asenapine's f...

Descripción completa

Detalles Bibliográficos
Autores principales: Marazziti, Donatella, Mucci, Federico, Baroni, Stefano, Piccinni, Armando
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2016
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4856245/
https://www.ncbi.nlm.nih.gov/pubmed/27190616
http://dx.doi.org/10.1002/ccr3.526
_version_ 1782430472337358848
author Marazziti, Donatella
Mucci, Federico
Baroni, Stefano
Piccinni, Armando
author_facet Marazziti, Donatella
Mucci, Federico
Baroni, Stefano
Piccinni, Armando
author_sort Marazziti, Donatella
collection PubMed
description Asenapine, a novel second‐generation antipsychotic is effective in acute treatment of bipolar I disorder patients in combination with mood stabilizers even in resistant cases. Although there is no evidence for asenapine's efficacy to be superior to currently available agents, asenapine's favorable weight and metabolic profile are of clinical interest.
format Online
Article
Text
id pubmed-4856245
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-48562452016-05-17 Asenapine augmentation in bipolar disorders: a case series Marazziti, Donatella Mucci, Federico Baroni, Stefano Piccinni, Armando Clin Case Rep Case Reports Asenapine, a novel second‐generation antipsychotic is effective in acute treatment of bipolar I disorder patients in combination with mood stabilizers even in resistant cases. Although there is no evidence for asenapine's efficacy to be superior to currently available agents, asenapine's favorable weight and metabolic profile are of clinical interest. John Wiley and Sons Inc. 2016-04-07 /pmc/articles/PMC4856245/ /pubmed/27190616 http://dx.doi.org/10.1002/ccr3.526 Text en © 2016 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd. This is an open access article under the terms of the Creative Commons Attribution‐NonCommercial‐NoDerivs (http://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Case Reports
Marazziti, Donatella
Mucci, Federico
Baroni, Stefano
Piccinni, Armando
Asenapine augmentation in bipolar disorders: a case series
title Asenapine augmentation in bipolar disorders: a case series
title_full Asenapine augmentation in bipolar disorders: a case series
title_fullStr Asenapine augmentation in bipolar disorders: a case series
title_full_unstemmed Asenapine augmentation in bipolar disorders: a case series
title_short Asenapine augmentation in bipolar disorders: a case series
title_sort asenapine augmentation in bipolar disorders: a case series
topic Case Reports
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4856245/
https://www.ncbi.nlm.nih.gov/pubmed/27190616
http://dx.doi.org/10.1002/ccr3.526
work_keys_str_mv AT marazzitidonatella asenapineaugmentationinbipolardisordersacaseseries
AT muccifederico asenapineaugmentationinbipolardisordersacaseseries
AT baronistefano asenapineaugmentationinbipolardisordersacaseseries
AT piccinniarmando asenapineaugmentationinbipolardisordersacaseseries

Ejemplares similares